Manufacturer record
Civron Pharmaceuticals: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Civron Pharmaceuticals (Himachal Pradesh) were declared Not of Standard Quality between March 2019 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
4 records linked to Civron Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Montelukast Tablets I.P. | CRT-250217Mfg 2025-02 · Exp 2027-01 | The sample is found to be Not of Standard Quality for the reason stated under Description.Description | CDL KolkataCDSCO lab | Jun 2026 |
| Nitroglycerin Controlled Release Tablets ( Nitromed-CR 2.6 Tablets) | CRT-190409Mfg 2019-04 · Exp 2021-03 | AssayAssay | RDTL ChandigarhCDSCO lab | Dec 2019 |
| Nitroglycerin Controlled Release Tablet (Nitromed-CR 6.4 Tablets) | CRT-190618Mfg 2019-06 · Exp 2021-05 | AssayAssay | RDTL ChandigarhCDSCO lab | Dec 2019 |
| VITAMIN A SUSPENSION IP (A to A) | CRS-181010Mfg 2018-10 · Exp 2020-03 | Assay of Vitamin A calculated as Vitamin A PalmitateAssay | RDTL ChandigarhState lab | Mar 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.